evt_NCT03152929_v1_v2_71a6c52c5537

{
  "changed_paths": [
    "/protocolSection/statusModule/statusVerifiedDate",
    "/protocolSection/statusModule/lastUpdateSubmitDate",
    "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
    "/protocolSection/statusModule/resultsFirstSubmitDate",
    "/protocolSection/outcomesModule/primaryOutcomes/0/description",
    "/protocolSection/outcomesModule/primaryOutcomes/0/reviewUnit",
    "/protocolSection/outcomesModule/primaryOutcomes/1/measure",
    "/protocolSection/outcomesModule/primaryOutcomes/1/description",
    "/protocolSection/outcomesModule/primaryOutcomes/1/reviewUnit",
    "/protocolSection/outcomesModule/primaryOutcomes/2/measure",
    "/protocolSection/outcomesModule/primaryOutcomes/2/description",
    "/protocolSection/outcomesModule/secondaryOutcomes/0/measure",
    "/protocolSection/outcomesModule/secondaryOutcomes/0/reviewUnit",
    "/protocolSection/outcomesModule/secondaryOutcomes/1/measure",
    "/protocolSection/outcomesModule/secondaryOutcomes/1/reviewUnit",
    "/protocolSection/outcomesModule/secondaryOutcomes/2/measure",
    "/protocolSection/outcomesModule/secondaryOutcomes/2/description",
    "/protocolSection/outcomesModule/secondaryOutcomes/3/measure",
    "/protocolSection/outcomesModule/secondaryOutcomes/3/description",
    "/protocolSection/outcomesModule/secondaryOutcomes/4/measure",
    "/protocolSection/outcomesModule/secondaryOutcomes/4/description",
    "/protocolSection/outcomesModule/secondaryOutcomes/5/measure",
    "/protocolSection/outcomesModule/secondaryOutcomes/5/description",
    "/protocolSection/contactsLocationsModule/locations/0/facility",
    "/hasResults",
    "/resultsSection",
    "/annotationSection",
    "/documentSection"
  ],
  "citation_text": "TrialDiff Evidence Record evt_NCT03152929_v1_v2_71a6c52c5537. ClinicalTrials.gov NCT03152929, versions 1-2. Evidence version 1.",
  "claims_not_supported": [
    "That the amendment was scientifically unjustified.",
    "That the change constitutes misconduct or wrongdoing.",
    "That sponsor intent can be inferred from this registry change.",
    "That the change caused or altered the trial's results.",
    "That the change was or was not disclosed in a manuscript.",
    "That TrialDiff determines regulatory compliance or non-compliance.",
    "That co-occurrence with results posting proves the outcome edit was harmless, administrative, or substantively benign.",
    "That event-class membership is a validated global review-priority ranking."
  ],
  "claims_supported": [
    "TrialDiff compared ClinicalTrials.gov record version 1 to version 2 for NCT03152929.",
    "The JSON Patch for this comparison has hash 0b62abbde3f4a428949d1698007f928e07ab90e663449b34a5e90f0a8881de95.",
    "The active deterministic rule set hash was 318445b9ad266f51fd10ef378645c753ba7a098e3e4395c3c457750dc5f88d86.",
    "The deterministic triage label was low; before timing adjustment it was low.",
    "The triage label is uncalibrated metadata, not a validated review-priority finding.",
    "The patch satisfied these deterministic event-class predicates: outcome_edit_cooccurs_with_results_posting.",
    "The timing context for the from-version record was post_recruitment.",
    "The changed JSON Pointer paths were: /protocolSection/statusModule/statusVerifiedDate, /protocolSection/statusModule/lastUpdateSubmitDate, /protocolSection/statusModule/lastUpdatePostDateStruct/date, /protocolSection/statusModule/resultsFirstSubmitDate, /protocolSection/outcomesModule/primaryOutcomes/0/description, /protocolSection/outcomesModule/primaryOutcomes/0/reviewUnit, /protocolSection/outcomesModule/primaryOutcomes/1/measure, /protocolSection/outcomesModule/primaryOutcomes/1/description, /protocolSection/outcomesModule/primaryOutcomes/1/reviewUnit, /protocolSection/outcomesModule/primaryOutcomes/2/measure, /protocolSection/outcomesModule/primaryOutcomes/2/description, /protocolSection/outcomesModule/secondaryOutcomes/0/measure, /protocolSection/outcomesModule/secondaryOutcomes/0/reviewUnit, /protocolSection/outcomesModule/secondaryOutcomes/1/measure, /protocolSection/outcomesModule/secondaryOutcomes/1/reviewUnit, /protocolSection/outcomesModule/secondaryOutcomes/2/measure, /protocolSection/outcomesModule/secondaryOutcomes/2/description, /protocolSection/outcomesModule/secondaryOutcomes/3/measure, /protocolSection/outcomesModule/secondaryOutcomes/3/description, /protocolSection/outcomesModule/secondaryOutcomes/4/measure, /protocolSection/outcomesModule/secondaryOutcomes/4/description, /protocolSection/outcomesModule/secondaryOutcomes/5/measure, /protocolSection/outcomesModule/secondaryOutcomes/5/description, /protocolSection/contactsLocationsModule/locations/0/facility, /hasResults, /resultsSection, /annotationSection, /documentSection.",
    "An outcome path changed between versions 1 and 2 in a patch that also carried a hasResults or resultsSection co-occurrence signal."
  ],
  "classification": {
    "calibration_status": "uncalibrated",
    "categories": [
      "results_reconciliation"
    ],
    "category": "results_reconciliation",
    "deterministic_rules": [],
    "event_class_rule_set_hash": "07957f8b90549d4f42387f51b471ecde9901b6db63bbc27b84c73631603407c0",
    "event_classes": [
      "outcome_edit_cooccurs_with_results_posting"
    ],
    "rule_set_hash": "318445b9ad266f51fd10ef378645c753ba7a098e3e4395c3c457750dc5f88d86",
    "severity": "low",
    "severity_pre_timing": "low",
    "timing_context": "post_recruitment",
    "triage_label": "low",
    "triage_rule_set_hash": "af5e5835e00a5fcfe2a17fd02b5fc244c2564104f93f78a1d77d7889f12a178b",
    "value_signals": [
      {
        "category": "results_reconciliation",
        "paths": [
          "/protocolSection/outcomesModule/primaryOutcomes/0/description",
          "/protocolSection/outcomesModule/primaryOutcomes/0/reviewUnit",
          "/protocolSection/outcomesModule/primaryOutcomes/1/description",
          "/protocolSection/outcomesModule/primaryOutcomes/1/measure",
          "/protocolSection/outcomesModule/primaryOutcomes/1/reviewUnit",
          "/protocolSection/outcomesModule/primaryOutcomes/2/description",
          "/protocolSection/outcomesModule/primaryOutcomes/2/measure",
          "/protocolSection/outcomesModule/secondaryOutcomes/0/measure",
          "/protocolSection/outcomesModule/secondaryOutcomes/0/reviewUnit",
          "/protocolSection/outcomesModule/secondaryOutcomes/1/measure",
          "/protocolSection/outcomesModule/secondaryOutcomes/1/reviewUnit",
          "/protocolSection/outcomesModule/secondaryOutcomes/2/description",
          "/protocolSection/outcomesModule/secondaryOutcomes/2/measure",
          "/protocolSection/outcomesModule/secondaryOutcomes/3/description",
          "/protocolSection/outcomesModule/secondaryOutcomes/3/measure",
          "/protocolSection/outcomesModule/secondaryOutcomes/4/description",
          "/protocolSection/outcomesModule/secondaryOutcomes/4/measure",
          "/protocolSection/outcomesModule/secondaryOutcomes/5/description",
          "/protocolSection/outcomesModule/secondaryOutcomes/5/measure"
        ],
        "severity": "low",
        "signal": "results_reconciliation_outcome_suppression"
      }
    ]
  },
  "event_id": "evt_NCT03152929_v1_v2_71a6c52c5537",
  "evidence_version": 1,
  "patch": [
    {
      "op": "replace",
      "path": "/protocolSection/statusModule/statusVerifiedDate",
      "value": "2023-03"
    },
    {
      "op": "replace",
      "path": "/protocolSection/statusModule/lastUpdateSubmitDate",
      "value": "2023-03-30"
    },
    {
      "op": "replace",
      "path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
      "value": "2023-04-21"
    },
    {
      "op": "add",
      "path": "/protocolSection/statusModule/resultsFirstSubmitDate",
      "value": "2023-03-30"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/0/description",
      "value": "Participants for whom Narcotics were used for pain during surgery"
    },
    {
      "op": "add",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/0/reviewUnit",
      "value": {
        "resetReasons": [
          "The Time Frame appears inconsistent with information provided here or in other parts of the record."
        ]
      }
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/1/measure",
      "value": "Post Anesthesia Care Unit (PACU) Narcotic Use"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/1/description",
      "value": "Participants for whom Narcotics were used in PACU"
    },
    {
      "op": "add",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/1/reviewUnit",
      "value": {
        "resetReasons": [
          "The Time Frame appears inconsistent with information provided here or in other parts of the record."
        ]
      }
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/2/measure",
      "value": "Postoperative Narcotic Use"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/primaryOutcomes/2/description",
      "value": "Participants for whom Narcotics were used postoperatively"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/0/measure",
      "value": "Pain Control Measured by Length of Operation"
    },
    {
      "op": "add",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/0/reviewUnit",
      "value": {
        "resetReasons": [
          "The Time Frame appears inconsistent with information provided here or in other parts of the record."
        ]
      }
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/1/measure",
      "value": "Pain Control Measured by Estimated Blood Loss"
    },
    {
      "op": "add",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/1/reviewUnit",
      "value": {
        "resetReasons": [
          "The Time Frame appears inconsistent with information provided here or in other parts of the record."
        ]
      }
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/2/measure",
      "value": "Participants With Postoperative Nausea"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/2/description",
      "value": "count of participants who reported nausea after surgery"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/3/measure",
      "value": "Pain Control Measured by Pain Scale"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/3/description",
      "value": "Pain measured on scale of one to ten, one being least amount of pain and ten the greatest."
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/4/measure",
      "value": "Pain Control Measured by the Use of Pain Pills Postoperatively"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/4/description",
      "value": "Participants who used narcotic pain pills postoperatively"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/5/measure",
      "value": "Pain Control Measured by Calls to Physicians Office Relating to Pain"
    },
    {
      "op": "replace",
      "path": "/protocolSection/outcomesModule/secondaryOutcomes/5/description",
      "value": "Number of phone calls made to physician office regarding pain"
    },
    {
      "op": "replace",
      "path": "/protocolSection/contactsLocationsModule/locations/0/facility",
      "value": "Esther L Peariso"
    },
    {
      "op": "replace",
      "path": "/hasResults",
      "value": true
    },
    {
      "op": "add",
      "path": "/resultsSection",
      "value": {
        "adverseEventsModule": {
          "description": "pain was not considered an adverse event unless it reached a grade 3 by CTCAE v4.0",
          "eventGroups": [
            {
              "deathsNumAffected": 0,
              "deathsNumAtRisk": 40,
              "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
              "id": "EG000",
              "otherNumAffected": 0,
              "otherNumAtRisk": 40,
              "seriousNumAffected": 0,
              "seriousNumAtRisk": 40,
              "title": "Paravertebral Block"
            },
            {
              "deathsNumAffected": 0,
              "deathsNumAtRisk": 49,
              "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
              "id": "EG001",
              "otherNumAffected": 0,
              "otherNumAtRisk": 49,
              "seriousNumAffected": 0,
              "seriousNumAtRisk": 49,
              "title": "Pectoral Nerve Block"
            }
          ],
          "frequencyThreshold": "5",
          "timeFrame": "Adverse events were collected from the time of surgery until the 2 week post op appointment"
        },
        "baselineCharacteristicsModule": {
          "denoms": [
            {
              "counts": [
                {
                  "groupId": "BG000",
                  "value": "40"
                },
                {
                  "groupId": "BG001",
                  "value": "49"
                },
                {
                  "groupId": "BG002",
                  "value": "89"
                }
              ],
              "units": "Participants"
            }
          ],
          "groups": [
            {
              "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
              "id": "BG000",
              "title": "Paravertebral Block"
            },
            {
              "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
              "id": "BG001",
              "title": "Pectoral Nerve Block"
            },
            {
              "description": "Total of all reporting groups",
              "id": "BG002",
              "title": "Total"
            }
          ],
          "measures": [
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "spread": "10.18",
                          "value": "65.15"
                        },
                        {
                          "groupId": "BG001",
                          "spread": "11.42",
                          "value": "64.24"
                        },
                        {
                          "groupId": "BG002",
                          "spread": "10.83",
                          "value": "64.65"
                        }
                      ]
                    }
                  ]
                }
              ],
              "dispersionType": "STANDARD_DEVIATION",
              "paramType": "MEAN",
              "title": "Age, Continuous",
              "unitOfMeasure": "years"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "40"
                        },
                        {
                          "groupId": "BG001",
                          "value": "49"
                        },
                        {
                          "groupId": "BG002",
                          "value": "89"
                        }
                      ],
                      "title": "Female"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "0"
                        },
                        {
                          "groupId": "BG001",
                          "value": "0"
                        },
                        {
                          "groupId": "BG002",
                          "value": "0"
                        }
                      ],
                      "title": "Male"
                    }
                  ]
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "title": "Sex: Female, Male",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "0"
                        },
                        {
                          "groupId": "BG001",
                          "value": "0"
                        },
                        {
                          "groupId": "BG002",
                          "value": "0"
                        }
                      ],
                      "title": "American Indian or Alaska Native"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "0"
                        },
                        {
                          "groupId": "BG001",
                          "value": "0"
                        },
                        {
                          "groupId": "BG002",
                          "value": "0"
                        }
                      ],
                      "title": "Asian"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "0"
                        },
                        {
                          "groupId": "BG001",
                          "value": "0"
                        },
                        {
                          "groupId": "BG002",
                          "value": "0"
                        }
                      ],
                      "title": "Native Hawaiian or Other Pacific Islander"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "1"
                        },
                        {
                          "groupId": "BG001",
                          "value": "1"
                        },
                        {
                          "groupId": "BG002",
                          "value": "2"
                        }
                      ],
                      "title": "Black or African American"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "39"
                        },
                        {
                          "groupId": "BG001",
                          "value": "48"
                        },
                        {
                          "groupId": "BG002",
                          "value": "87"
                        }
                      ],
                      "title": "White"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "0"
                        },
                        {
                          "groupId": "BG001",
                          "value": "0"
                        },
                        {
                          "groupId": "BG002",
                          "value": "0"
                        }
                      ],
                      "title": "More than one race"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "0"
                        },
                        {
                          "groupId": "BG001",
                          "value": "0"
                        },
                        {
                          "groupId": "BG002",
                          "value": "0"
                        }
                      ],
                      "title": "Unknown or Not Reported"
                    }
                  ]
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "title": "Race (NIH&#x2F;OMB)",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "BG000",
                          "value": "40"
                        },
                        {
                          "groupId": "BG001",
                          "value": "49"
                        },
                        {
                          "groupId": "BG002",
                          "value": "89"
                        }
                      ]
                    }
                  ],
                  "title": "United States"
                }
              ],
              "paramType": "NUMBER",
              "title": "Region of Enrollment",
              "unitOfMeasure": "participants"
            }
          ]
        },
        "moreInfoModule": {
          "certainAgreement": {
            "piSponsorEmployee": true
          },
          "limitationsAndCaveats": {
            "description": "Study was terminated early due to clinical practice outpacing the science of the trial.\nAt the time of stopping enrollment, pectoral nerve blocks were being used standardly.\nTherefore, we could not ethically continue to randomize patients to both arms."
          },
          "pointOfContact": {
            "email": "marianne.melnik@corewellhealth.org",
            "organization": "Spectrum Health",
            "phone": "616-486-6333",
            "title": "Marianne Melnik"
          }
        },
        "outcomeMeasuresModule": {
          "outcomeMeasures": [
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "26"
                        },
                        {
                          "groupId": "OG001",
                          "value": "29"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "40"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Participants for whom Narcotics were used for pain during surgery",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "reportingStatus": "POSTED",
              "reviewUnit": {
                "resetReasons": [
                  "The Time Frame appears inconsistent with information provided here or in other parts of the record."
                ]
              },
              "timeFrame": "First 24 hours post-PACU (or until discharge)",
              "title": "Intraoperative Narcotic Use",
              "type": "PRIMARY",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "20"
                        },
                        {
                          "groupId": "OG001",
                          "value": "33"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "40"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Participants for whom Narcotics were used in PACU",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "reportingStatus": "POSTED",
              "reviewUnit": {
                "resetReasons": [
                  "The Time Frame appears inconsistent with information provided here or in other parts of the record."
                ]
              },
              "timeFrame": "First 24 hours post-PACU (or until discharge)",
              "title": "Post Anesthesia Care Unit (PACU) Narcotic Use",
              "type": "PRIMARY",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "3"
                        },
                        {
                          "groupId": "OG001",
                          "value": "1"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "40"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Participants for whom Narcotics were used postoperatively",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "reportingStatus": "POSTED",
              "timeFrame": "First 24 hours post-PACU (or until discharge)",
              "title": "Postoperative Narcotic Use",
              "type": "PRIMARY",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "spread": "16.42",
                          "value": "61.80"
                        },
                        {
                          "groupId": "OG001",
                          "spread": "20.20",
                          "value": "64.14"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "40"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Measuring pain control by how long (in minutes) patient is in surgery",
              "dispersionType": "Standard Deviation",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "MEAN",
              "reportingStatus": "POSTED",
              "reviewUnit": {
                "resetReasons": [
                  "The Time Frame appears inconsistent with information provided here or in other parts of the record."
                ]
              },
              "timeFrame": "2 weeks postoperative",
              "title": "Pain Control Measured by Length of Operation",
              "type": "SECONDARY",
              "unitOfMeasure": "minutes"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "spread": "8.3",
                          "value": "10.85"
                        },
                        {
                          "groupId": "OG001",
                          "spread": "12.29",
                          "value": "13.8"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "40"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Measuring blood loss (in ml) during surgery",
              "dispersionType": "Standard Deviation",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "MEAN",
              "reportingStatus": "POSTED",
              "reviewUnit": {
                "resetReasons": [
                  "The Time Frame appears inconsistent with information provided here or in other parts of the record."
                ]
              },
              "timeFrame": "2 weeks postoperative",
              "title": "Pain Control Measured by Estimated Blood Loss",
              "type": "SECONDARY",
              "unitOfMeasure": "milliliters"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "0"
                        },
                        {
                          "groupId": "OG001",
                          "value": "1"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "39"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "count of participants who reported nausea after surgery",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "populationDescription": "Paravertebral population had one non-reporting participant",
              "reportingStatus": "POSTED",
              "timeFrame": "2 weeks postoperative",
              "title": "Participants With Postoperative Nausea",
              "type": "SECONDARY",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "spread": "1.33",
                          "value": "2"
                        },
                        {
                          "groupId": "OG001",
                          "spread": "1.4",
                          "value": "2.4"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "40"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Pain measured on scale of one to ten, one being least amount of pain and ten the greatest.",
              "dispersionType": "Standard Deviation",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "MEAN",
              "reportingStatus": "POSTED",
              "timeFrame": "2 weeks postoperative",
              "title": "Pain Control Measured by Pain Scale",
              "type": "SECONDARY",
              "unitOfMeasure": "score on a scale"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "20"
                        },
                        {
                          "groupId": "OG001",
                          "value": "24"
                        }
                      ]
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "39"
                    },
                    {
                      "groupId": "OG001",
                      "value": "49"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Participants who used narcotic pain pills postoperatively",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "populationDescription": "Paravertebral Block arm had one participant with no response",
              "reportingStatus": "POSTED",
              "timeFrame": "2 weeks postoperative",
              "title": "Pain Control Measured by the Use of Pain Pills Postoperatively",
              "type": "SECONDARY",
              "unitOfMeasure": "Participants"
            },
            {
              "classes": [
                {
                  "categories": [
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "38"
                        },
                        {
                          "groupId": "OG001",
                          "value": "44"
                        }
                      ],
                      "title": "no phone calls to physician office regarding pain"
                    },
                    {
                      "measurements": [
                        {
                          "groupId": "OG000",
                          "value": "1"
                        },
                        {
                          "groupId": "OG001",
                          "value": "4"
                        }
                      ],
                      "title": "1 phone call to physician office regarding pain"
                    }
                  ]
                }
              ],
              "denoms": [
                {
                  "counts": [
                    {
                      "groupId": "OG000",
                      "value": "39"
                    },
                    {
                      "groupId": "OG001",
                      "value": "48"
                    }
                  ],
                  "units": "Participants"
                }
              ],
              "description": "Number of phone calls made to physician office regarding pain",
              "groups": [
                {
                  "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG000",
                  "title": "Paravertebral Block"
                },
                {
                  "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
                  "id": "OG001",
                  "title": "Pectoral Nerve Block"
                }
              ],
              "paramType": "COUNT_OF_PARTICIPANTS",
              "populationDescription": "one participant in each arm did not have a response recorded",
              "reportingStatus": "POSTED",
              "timeFrame": "2 weeks postoperative",
              "title": "Pain Control Measured by Calls to Physicians Office Relating to Pain",
              "type": "SECONDARY",
              "unitOfMeasure": "Participants"
            }
          ]
        },
        "participantFlowModule": {
          "groups": [
            {
              "description": "<p>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Paravertebral Block: 20-30 mL 0.5% Ropivacaine</p>",
              "id": "FG000",
              "title": "Paravertebral Block"
            },
            {
              "description": "<p>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</p><p>Pectoral Nerve Block: 20-30 mL 0.5% Ropivacaine</p>",
              "id": "FG001",
              "title": "Pectoral Nerve Block"
            }
          ],
          "periods": [
            {
              "milestones": [
                {
                  "achievements": [
                    {
                      "groupId": "FG000",
                      "numSubjects": "40"
                    },
                    {
                      "groupId": "FG001",
                      "numSubjects": "49"
                    }
                  ],
                  "type": "STARTED"
                },
                {
                  "achievements": [
                    {
                      "groupId": "FG000",
                      "numSubjects": "40"
                    },
                    {
                      "groupId": "FG001",
                      "numSubjects": "49"
                    }
                  ],
                  "type": "COMPLETED"
                },
                {
                  "achievements": [
                    {
                      "groupId": "FG000",
                      "numSubjects": "0"
                    },
                    {
                      "groupId": "FG001",
                      "numSubjects": "0"
                    }
                  ],
                  "type": "NOT COMPLETED"
                }
              ],
              "title": "Overall Study"
            }
          ]
        }
      }
    },
    {
      "op": "add",
      "path": "/annotationSection",
      "value": {
        "annotationModule": {
          "unpostedAnnotation": {
            "unpostedEvents": [
              {
                "date": "2023-04-20",
                "type": "RESET"
              }
            ],
            "unpostedResponsibleParty": "Spectrum Health Hospitals"
          }
        }
      }
    },
    {
      "op": "add",
      "path": "/documentSection",
      "value": {
        "largeDocumentModule": {
          "largeDocs": [
            {
              "date": "2018-03-30",
              "filename": "Prot_SAP_000.pdf",
              "hasIcf": false,
              "hasProtocol": true,
              "hasSap": true,
              "label": "Study Protocol and Statistical Analysis Plan",
              "size": 200798,
              "typeAbbrev": "Prot_SAP",
              "uploadDate": "2023-02-22T09:29"
            }
          ]
        }
      }
    }
  ],
  "provenance": {
    "from_snapshot_hash": "2ced69127508c6c8ead70f79259826564553712e529903b648b0c060489af183",
    "materiality_event_hash": "b0da6c454d368ab3ebf1a615bd28d6708c973a4c5dd341e4cef14608004c9171",
    "patch_hash": "0b62abbde3f4a428949d1698007f928e07ab90e663449b34a5e90f0a8881de95",
    "patch_raw_hash": "e629c8b9d3185a5cb92e5bec367e9582691c53e6be402cb3bec4b756f307cc96",
    "patch_source": "ctgov_internal_history",
    "patch_source_url": "https://clinicaltrials.gov/api/int/studies/NCT03152929/history/1?patchToVersion=2",
    "to_snapshot_hash": "277c1d27b1ed7ff1058fe9e4c9a91b2c6e1e50a38f60971f6b1cc2813f8e29ff"
  },
  "review_question": "What source document explains this registry amendment, and does it change interpretation of the trial record?",
  "schema": "trialdiff.evidence_record",
  "trial": {
    "clinicaltrials_gov_url": "https://clinicaltrials.gov/study/NCT03152929",
    "nct_id": "NCT03152929"
  },
  "versions": {
    "from_version": 1,
    "submitted_date": "2023-03-30",
    "to_version": 2
  }
}